Characteristics associated with achievement of remission with venetoclax and azacitidine. (A) Univariable odds ratios for not achieving CR/CRi (factors with odds ratio <1 are associated with achievement of CR/CRi). (B) Rate of CR/CRi in clinical and genomic subgroups. (C) Cumulative incidence of relapse for patients who achieved CR/CRi.